Found 5 matching trials
Bioequivalence of 5 Tablets of 100 mg Versus 2 Tablets of 250 mg TF3 of Tepotinib
PHASE1This study investigated the bioequivalence of the 100 milligrams (mg) and 2...
Tepotinib With Gefitinib in Participants With Locally Advanced or Metastatic NSCLC (INSIGHT)
PHASE1This is a multi-center, open-label, randomized, Phase 1b/2 study to determi...
Location
Beijing Cancer Hospital
Study of Tepotinib Combined With Cetuximab in Participants With Left-Sided RAS/BRAF Wild Type Metastatic Colorectal Cancer (PERSPECTIVE)
PHASE2The purpose of this study was to assess the preliminary antitumor activity,...
POTENT - Tepotinib in Combination With Pembrolizumab in NSCLC
PHASE1This clinical study is looking at the combination of two experimental drugs...
Status
Active Not Recruiting
Location
DDU, Royal Marsden Hospital NHS Foundation Trust
Bioequivalence of TF3 and TF2 and Effect of Food on the PK of Tepotinib
PHASE1The main purpose of the study was to demonstrate bioequivalence between the...